This message was posted by a user wishing to remain anonymous
Are there instances in which the FDA has designated more than one reference standard for generic product development? My understanding is that the FDA designates only one reference standard. If that reference standard is changed (due to citizen petition or FDA decision), the former reference standard loses its designation when the alternative product is designated as the reference standard.
Is my understanding correct?
Thank you!